page logo & home link

acompio - business directory and market place United States of America

Goldfinch Bio

With our sole focus on kidney diseases, we aspire to be the world's leading precision medicine kidney company. There are few therapeutic options that target the underlying cause of disease. Our solution to address this growing need is applying precision medicine to pioneer the discovery, development and commercialization of kidney disease treatments.
Historically, there has been a 'one size fits all' approach to treating kidney disease. This has been due to a lack of understanding of kidney disease at the molecular level.
Thanks to a growing understanding of kidney biology and genetics, including pioneering research by the founders of Goldfinch, the scientific community is starting to understand the heterogeneity inherent in kidney disease.

215 First Street

02142 Cambridge

Massachusetts


Phone: 617 /3374200

last update on 07/14/2021

Opening Hours
Monday 08:00  - 17:00
Tuesday 08:00  - 17:00
Wednesday 08:00  - 17:00
Thursday 08:00  - 17:00
Friday 08:00  - 17:00
Saturday closed
Sunday closed
Ratings

Please rate the company on the basis of the following criteria from 1 star (poor) to 5 stars (very good).

Availability

Price/Service

Service/Quality

Work within schedule

For security reasons your IP is saved!

Goldfinch Bio did not receive any ratings yet.
Map
Description
With our sole focus on kidney diseases, we aspire to be the world's leading precision medicine kidney company. There are few therapeutic options that target the underlying cause of disease. Our solution to address this growing need is applying precision medicine to pioneer the discovery, development and commercialization of kidney disease treatments.
Historically, there has been a 'one size fits all' approach to treating kidney disease. This has been due to a lack of understanding of kidney disease at the molecular level.
Thanks to a growing understanding of kidney biology and genetics, including pioneering research by the founders of Goldfinch, the scientific community is starting to understand the heterogeneity inherent in kidney disease.
Status
The correctness of the entry was confirmed on 07/13/2021.
This company cares for its listings. Checked listing
Generated in 0.370 seconds (3) 05.07.2021 10:05 (9a512)
acompio - business directory and market place uses cookies to improve your online experience. By using our site you agree to the use of cookies. Further information